|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Prepaid expense | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Inventory deposits | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and Equipment, net | ||||||||||||||||||||
| OTHER NON-CURRENT ASSETS: | ||||||||||||||||||||
| Goodwill and other intangible assets | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Lease deposits and other | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Right-of-use lease assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Total Other Assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||||
| Accounts payable and other payables | ||||||||||||||||||||
| Accrued expense and other | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Loan – Director – related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Officer | ||||||||||||||||||||
| Director | ||||||||||||||||||||
| Total loan – Director – related party | ||||||||||||||||||||
| Loans – Working capital, net | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total loans – Working capital, net | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Loan | ||||||||||||||||||||
| Officer | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Director | ||||||||||||||||||||
| Line of credit | ||||||||||||||||||||
| Right-of-use lease liability, current | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Right-of-use lease liability, long-term | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY: | ||||||||||||||||||||
| Preferred Shares, value | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Series E Preferred Stock | ||||||||||||||||||||
| Common stock, $0.001 par value; 600,000,000 shares authorized; 21,004,164 and 3,362 issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Noncontrolling interest in American Rebel Licensing NIL I, Inc. | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| TOTAL STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...
